Ayman Akil

489 total citations
16 papers, 373 citations indexed

About

Ayman Akil is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Ayman Akil has authored 16 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Virology and 3 papers in Molecular Biology. Recurrent topics in Ayman Akil's work include HIV Research and Treatment (4 papers), HIV/AIDS Research and Interventions (4 papers) and Reproductive tract infections research (3 papers). Ayman Akil is often cited by papers focused on HIV Research and Treatment (4 papers), HIV/AIDS Research and Interventions (4 papers) and Reproductive tract infections research (3 papers). Ayman Akil collaborates with scholars based in United States, Spain and Australia. Ayman Akil's co-authors include Lisa C. Rohan, Marilyn Cost, Charlene S. Dezzutti, Bernard J. Moncla, Mingguang Li, Michael A. Parniak, Bríd Devlin, Robert R. Bies, Jodi Skiles and David R. Friend and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Optics Letters and International Journal of Pharmaceutics.

In The Last Decade

Ayman Akil

16 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ayman Akil United States 11 108 83 67 62 49 16 373
Melanie R. Nicol United States 17 477 4.4× 48 0.6× 191 2.9× 125 2.0× 8 0.2× 52 811
Erik P. Sandefer United States 14 80 0.7× 24 0.3× 40 0.6× 36 0.6× 292 6.0× 27 577
Ayyappa Chaturvedula United States 12 132 1.2× 6 0.1× 49 0.7× 40 0.6× 95 1.9× 29 387
Thuy Tien T. Tran United States 10 116 1.1× 24 0.3× 61 0.9× 97 1.6× 4 0.1× 20 479
Annie Fang United States 13 155 1.4× 8 0.1× 117 1.7× 45 0.7× 12 0.2× 29 394
Rustin D. Crutchley United States 12 233 2.2× 16 0.2× 84 1.3× 110 1.8× 4 0.1× 27 430
Katya Govender South Africa 10 110 1.0× 17 0.2× 62 0.9× 50 0.8× 15 0.3× 16 235
Jonathan E. Constance United States 16 116 1.1× 21 0.3× 101 1.5× 4 0.1× 10 0.2× 35 575
Daniel Pearce United States 10 378 3.5× 29 0.3× 347 5.2× 73 1.2× 3 0.1× 17 698
Mamunur Rashid United States 10 161 1.5× 19 0.2× 111 1.7× 8 0.1× 6 0.1× 14 846

Countries citing papers authored by Ayman Akil

Since Specialization
Citations

This map shows the geographic impact of Ayman Akil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayman Akil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayman Akil more than expected).

Fields of papers citing papers by Ayman Akil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayman Akil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayman Akil. The network helps show where Ayman Akil may publish in the future.

Co-authorship network of co-authors of Ayman Akil

This figure shows the co-authorship network connecting the top 25 collaborators of Ayman Akil. A scholar is included among the top collaborators of Ayman Akil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayman Akil. Ayman Akil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Park, K., Edurne Arriola, M. Pérol, et al.. (2024). P1.12B.10 Dose Adjustments and Exposure-Response Associated with Selpercatinib in Patients with Advanced NSCLC. Journal of Thoracic Oncology. 19(10). S205–S205. 1 indexed citations
2.
Gong, Xiaohua, Ayman Akil, Tao Ji, et al.. (2023). Population pharmacokinetic and exposure‐response analyses of pemigatinib in patients with advanced solid tumors including cholangiocarcinoma. CPT Pharmacometrics & Systems Pharmacology. 12(11). 1784–1794. 1 indexed citations
3.
Bies, Robert R., et al.. (2023). Deep Learning Methods Applied to Drug Concentration Prediction of Olanzapine. Pharmaceutics. 15(4). 1139–1139. 12 indexed citations
4.
Akil, Ayman, et al.. (2020). The impact of a pharmacist‐designed mobile application on blood pressure control and medication adherence in patients with hypertension. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 3(7). 1286–1295. 6 indexed citations
5.
Patel, Sravan Kumar, et al.. (2019). Delineating the effects of hot-melt extrusion on the performance of a polymeric film using artificial neural networks and an evolutionary algorithm. International Journal of Pharmaceutics. 571. 118715–118715. 10 indexed citations
7.
Cioffi, Catherine E., Shelley Caltharp, Alyssa M. Krasinskas, et al.. (2019). Development of a Plasma Screening Panel for Pediatric Nonalcoholic Fatty Liver Disease Using Metabolomics. Hepatology Communications. 3(10). 1311–1321. 37 indexed citations
8.
Akil, Ayman, et al.. (2018). Impact of a Pharmacist-Led Intervention on 30-Day Readmission and Assessment of Factors Predictive of Readmission in African American Men With Heart Failure. American Journal of Men s Health. 13(1). 1817092183–1817092183. 16 indexed citations
9.
Guggenmos, Alexander, Ayman Akil, Marcus Ossiander, et al.. (2016). Attosecond photoelectron streaking with enhanced energy resolution for small-bandgap materials. Optics Letters. 41(16). 3714–3714. 5 indexed citations
10.
Akil, Ayman, Qing Zhang, Christen L. Mumaw, et al.. (2015). Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation.. Publisher. 1 indexed citations
11.
Akil, Ayman, Robert R. Bies, Bruce G. Pollock, et al.. (2015). A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer’s disease patients with agitation. Journal of Pharmacokinetics and Pharmacodynamics. 43(1). 99–109. 16 indexed citations
12.
Akil, Ayman, Qing Zhang, Christen L. Mumaw, et al.. (2015). Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 21(10). 1739–1745. 60 indexed citations
13.
Akil, Ayman, Hrushikesh Agashe, Charlene S. Dezzutti, et al.. (2014). Formulation and Characterization of Polymeric Films Containing Combinations of Antiretrovirals (ARVs) for HIV Prevention. Pharmaceutical Research. 32(2). 458–468. 37 indexed citations
14.
Akil, Ayman, Bríd Devlin, Marilyn Cost, & Lisa C. Rohan. (2014). Increased Dapivirine Tissue Accumulation through Vaginal Film Codelivery of Dapivirine and Tenofovir. Molecular Pharmaceutics. 11(5). 1533–1541. 30 indexed citations
15.
Cost, Marilyn, Charlene S. Dezzutti, Meredith R. Clark, et al.. (2012). Characterization of UC781-Tenofovir Combination Gel Products for HIV-1 Infection Prevention in anEx VivoEctocervical Model. Antimicrobial Agents and Chemotherapy. 56(6). 3058–3066. 23 indexed citations
16.
Akil, Ayman, Michael A. Parniak, Charlene S. Dezzutti, et al.. (2011). Development and characterization of a vaginal film containing dapivirine, a non-nucleoside reverse transcriptase inhibitor (NNRTI), for prevention of HIV-1 sexual transmission. Drug Delivery and Translational Research. 1(3). 209–222. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026